Research Grade Vanucizumab
Overview
Catalog No.
HT073026
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Purity
>95% purity as determined by SDS-PAGE.
Clonality
Monoclonal
Isotype
human IgG1 - kappa - lambda with half-IG VL-CH1/VH-CK crossover
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Target
Vascular endothelial growth factor A, VPF, VEGFA, VEGF, Vascular permeability factor, VEGF-A, ANG-2, ANGPT2, Angiopoietin-2
Purification
Protein A/G purified from cell culture supernatant.
Endotoxin level
Please contact the lab for this information.
Expression system
Mammalian Cells
Accession
P15692 & O15123
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternative name
Bispecific, RG-7221, RG7221, RO5520985, CAS:1448221-05-3
Note
For research use only. Not suitable for clinical or therapeutic use.
Images
Bioactivity
Detects Human VEGFA in indirect ELISAs.
SEC-HPLC
SEC-HPLC detection for Research Grade Vanucizumab.
Bioactivity
Detects Human ANGPT2 in indirect ELISAs.
Flow CytoMetry
Flow-cytometry using FITC anti-human VEGFA&ANGPT2 antibody. U87 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human VEGFA&ANGPT2 monoclonal antibody (Catalog: HT073026, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.